Patents expiring in 2029

US 2009169611

Gel-Formulations of Hydrophobic Photosensitizers for Mucosal Applications

ALBRECHT VOLKER [DE] · Granted Thu Jul 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jun 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7557212

Tricyclic derivatives as LTD4 antagonists

Laboratories Almirall, S.A. · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7557138

5-phenoxyalkoxypsoralens and methods for selective inhibition of the voltage gated Kv1.3 potassium channel

The Regents of the University of California · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7557210

2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7557194

Antibody materials for an IBD-associated polypeptide

The Regents of the University of California · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7557096

Synthesis of combretastatin A-4 prodrugs and trans-isomers thereof

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7557081

Alpha-1-acid glycoprotein for the treatment of diabetes

Essential Skincare, LLC · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7557196

hGC-1, a gene encoding a member of the olfactomedin-related protein family

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7557207

Spiro 2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7557106

Substituted pyrimidines useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7557126

Diphenylmethyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7557084

IL-18 specific polypeptides and therapeutic uses thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7556926

Methods for screening insulin-sensitizing agents

Takeda Pharmaceutical Company Limited · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7556804

Anti-HGF-R antibodies and their use

UNIVERSITÀ DEGLI STUDI DEL PIEMONTE ORIENTALE “AMEDEO AVOGADRO” · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7556942

Tumor suppressor designated Hippo

The Board of Regents of the University of Texas System · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7556927

Methods for diagnosing, imaging and treating atherosclerotic disease

The Regents of the University of California · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7557251

Production of gossypol co-crystals

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7557247

Crystalline form of β2 adrenergic receptor agonist

Theravance, Inc. · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2009084970

3-N-PHÉNYL-1,3,4-OXADIAZOLONES 5-O-SUBSTITUÉES POUR UNE UTILISATION MÉDICALE

BIAL PORTELA & COMPANHIA S A [PT] · Granted Thu Jul 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jul 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7560105

Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigen-specific T cell responses

Leids Universitair Medisch Centrum · Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7560466

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

Rigel Pharmaceuticals, Inc. · Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7560440

Regulation of angiogenesis with zinc finger proteins

Sangamo Biosciences, Inc. · Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7560437

Nucleic acid compositions for eliciting an immune response against telomerase reverse transcriptase

The Regents of the University of Colorado · Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7560265

Compositions for regulation of tumor necrosis factor-alpha

The Regents of the University of Colorado, a Body Corporate · Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7560263

Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7560436

Methods of treating gastrointestinal inflammation

The Regents of the University of California · Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7560471

Indolylpiperidine derivatives as potent antihistaminic and antiallergic agents

Laboratories Almirall, S.A. · Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7560229

Methods of use of the enzymes of mycothiol synthesis

The Regents of the University of California · Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7560118

Attenuated dengue virus comprising mutations in the NS3 gene

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7560469

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2708406

COMPOSITION DE VACCIN ANTI-ALLERGIE POUR UNE ADMINISTRATION MUCOSALE

ALK ABELLO AS [DK] · Granted Thu Jul 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jul 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563593

Method for preparing cell cultures from biological specimens for assaying secreted factors

Precision Therapeutics, Inc. · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563795

Phenyl-piperazine derivatives as modulators of muscarinic receptors

Vertex Pharmaceuticals Incorporated · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563930

Crystal forms of Cinacalcet HCI and processes for their preparation

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563883

Recombinant P. falciparum merozoite protein-142 vaccine

The United States of America as represented by the Secretary of the Army · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563459

Methods and compositions for regenerating tissue

The United States of America as represented by the Department of Vetrans Affairs · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563918

Solid and crystalline ibandronate sodium and processes for preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563874

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

The Regents of the University of California · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563920

Methods for preparing 2-methoxyisobutylisonitrile and tetrakis(2-methoxyisobutylisonitrile)copper(I) tetrafluoroborate

Draximage Limited · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563446

Methods and compositions for inducing autoimmunity in the treatment of cancers

The Board of Regents of the University of Texas System · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563457

Nanoparticle assembled hollow spheres

The Regents of the University of California · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563777

Method to induce neovascular formation and tissue regeneration

Fundacion Universitaria Dr. Rene G. Favaloro · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563585

Methods of assaying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein (TXNL)

Rigel Pharmaceuticals, Inc. · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563596

Method of modulating tissue growth using Frzb protein

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563766

Methods and compositions for the promotion of a hair growth utilizing actin binding peptides

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563892

Prodrugs of 2,4 pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2079529

ANTIMIKROBIELLE ZUSAMMENSETZUNG MIT EINEM GEHALT AN BISPYRIDINIUMALKAN (OCTENIDIN-DIHYDROCHLORID)

AIR LIQUIDE SANTE INT [FR] · Granted Wed Jul 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Jul 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2079730

MGLUR5-MODULATOREN

ASTRAZENECA AB [SE] · Granted Wed Jul 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Jul 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)